IP3R-mediated Ca2+ release is modulated by anandamide in isolated cardiac nuclei

Journal of Molecular and Cellular Cardiology

Volumn 45, Issue 6, 2008, Pages 804-811

  Currie, Susan ^a   Rainbow, Richard D ^a   Ewart, Marie ann ^a   Kitson, Susan ^a   Pliego, Esperanza Herradon ^b   Kane, Kathleen A ^a   McCarron, John G ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

Calcium release; Cannabinoid receptors; Cardiac; Inositol trisphosphate receptor; Nuclear

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; CAFFEINE; CALCIUM ION; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; INOSITOL TRISPHOSPHATE; TETRACAINE;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; GUINEA PIG; HEART ATRIUM; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART PROTECTION; IMMUNOBLOTTING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ANIMALS; ARACHIDONIC ACIDS; CALCIUM; CARDIOTONIC AGENTS; CELL NUCLEUS; ENDOCANNABINOIDS; GUINEA PIGS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MALE; MYOCARDIUM; PHOSPHOPROTEINS; POLYUNSATURATED ALKAMIDES; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RNA-BINDING PROTEINS;

EID: 55649098166     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.07.005     Document Type: Article

References (46)

1. Bers D.M. Cardiac excitation-contraction coupling. Nature 415 (2002) 198-205
2. Perez P.J., Ramos-Franco J., Fill M., and Mignery G.A. Identification and functional reconstitution of the type 2 inositol 1,4,5 trisphosphate receptor from ventricular cardiac myocytes. J. Biol. Chem. 272 (1997) 23961-23969
3. 2+ signalling in cardiac myocyte excitation-transcription coupling. J. Clin. Invest. 116 (2006) 675-682
4. Bare D.J., Kettlun C.S., Liang M., Bers D.M., and Mignery G.A. Cardiac type 2 inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 280 (2005) 15912-15920
5. 1R's regulate cardiovascular function in hypertension. Circulation 110 (2004) 1996-2002
6. Joyeux M., Arnaud C., Godin-Ribuok D., Demange P., Lamontagne D., and Ribuok C. Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts. Cardiovasc. Res 55 (2002) 619-625
7. Underdown N.J., Hiley C.R., and Ford W.R. Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. Br. J. Pharmacol. 146 (2005) 809-816
8. Lepicier P., Poirier A.B., Lagneux C., Sirois M.G., Servant M., and Lamontagne D. Endothelial CB1 receptors confer cardiac protection through nitric oxide production. Cell. Cardiol. 37 (2004) 197-198
9. Sterin-Borda L., Del Zar C.F., and Borda E.S. Differential CB1 and CB2 cannabinoid receptor inotropic response of rat isolated atria: endogenous signal transduction pathways. Biochem. Pharmacol. 69 (2005) 1705-1713
10. Zhuang S.Y., Bridges D., Grigorenko E., McCloud S., Boon A., Hampson R.E., et al. Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores. Neuropharmacology 48 (2005) 1086-1096
11. Vasquez C., Navarro-Polanco R., Hernandez G., Ruiz J., Guerra D.G., Baltazar L.M., et al. Cannabinoids and dopamine receptors action on calcium current in rat neurones. Can. J. Neurol. Sci. 32 (2005) 529-537
12. q/11 G proteins. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 19144-19149
13. 2+ release channels during end stage heart failure. J. Clin. Invest. 95 (1995) 888-894
14. Yamada J., Ohkusa T., Nao T., Ueyama T., Yano M., and Kobayashi S. Up-regulation of IP3R expression in atrial tissue in patients with chronic atrial fibrillation. J. Cardiol. 39 (2002) 57-58
15. i/o dependent activation of PLC in the bovine ciliary muscle. Eur. J. Pharmacol. 494 (2004) 55-62
16. Sugiura T., Kodaka T., Kondo S., Tonegawa T., Nakane S., Kishimoto S., et al. 2-arachidonylglycerol, a putative endogenous CB receptor ligand, induces rapid, transient elevation of intracellular calcium in NG108-15 cells. Biochem. Biophys. Res. Commun. 229 (1996) 58-64
17. Currie S., Quinn F.R., Sayeed R.A., Duncan A.M., Kettlewell S., and Smith G.L. Regional differences in expression and function of ryanodine receptors in a rabbit model of left ventricular dysfunction. J. Mol. Cell. Cardiol. 39 (2005) 309-317
18. Nair K.G., Rabinowitz M., and Chen M.H. Characterisation of the ribonucleic acid synthesised in an isolated nuclear system from rat heart muscle. Biochemistry 6 (1967) 1898-1902
19. Czubryt M.P., Ramjiawan B., Gilchourist J.S.C., Massaeli H., and Pierce G.N. The presence and partitioning of calcium binding proteins in hepatic and cardiac nuclei. J. Mol. Cell. Cardiol. 28 (1996) 455-465
20. 2+ATPase type 2 (SERCA 2) in cardiac sarcoplasmic reticulum from rabbits with heart failure. Cardiovasc. Res 41 (1999) 135-146
21. 2+ signalling in the heart. J. Physiol. 584 (2007) 601-611
22. 2+ store in guinea pig colonic smooth muscle. J. Physiol 516 (1999) 149-161
23. Hymer W.C., and Kuff E.L. Isolation of nuclei from mammalian tissues through the use of triton-X-100. J. Histochem. Cytochem. 12 (1964) 359-363
24. Jackowski G., and Liew C.C. Fractionation of rat ventricular nuclei. Biochem. J. 188 (1980) 363-373
25. Widnell C.C., and Tata J.R. Isolation of enzymatically active nuclei from the rat heart and uterus. Biochem. J. 92 (1964) 313-317
26. Gizak A., and Dzugaj A. FBPase is in the nuclei of cardiomyocytes. FEBS Lett. 539 (2003) 51-55
27. 2+ signalling and the generation of arrhythmias in rat atrial myocytes. J. Physiol 541 (2002) 395-409
28. 123I-labelled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. Eur. J. Pharmacol. 307 (1996) 331-338
29. Pertwee R.G. Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sci. 76 (2005) 1307-1324
30. Ross R.A., Brockie H.C., Stevenson L.A., Murphy V.L., Templeton F., Makriyannis A., et al. Agonist-inverse agonist characterisation at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630. Br. J. Pharmacol. 126 (1999) 665-672
31. Ford W.R., Honan S.A., White R., and Hiley C.R. Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilator responses in rat isolated hearts. Br. J. Pharmacol. 135 (2002) 1191-1198
32. Bonz A., Laser M., Kullmer S., Kniesch S., Babin-Ebell J., and Popp V. Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle. J. Cardiovasc. Pharmacol. 41 (2003) 657-664
33. O'Sullivan S.E., Kendall D.A., and Randall M.D. Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries. Br. J. Pharmacol. 141 (2004) 803-812
34. Mukhopadhyay S., Chapnick B.M., and Howlett A.C. Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. Am. J. Physiol. 282 (2002) H2046-H2054
35. Pacher P., Batkai S., and Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev 58 (2006) 389-462
36. Ugdyzhekova D.S., Bernatskaya N.A., Stefano J.B., Graier V.F., Tam S.W., and Mekhoulam R. Endogenous cannabinoid anandamide increases heart resistance to arrhythmogenic effects of epinephrine: role of CB1 and CB2 receptors. Bull. Exp. Biol. Med. 131 (2001) 251-253
37. Krylatov A.V., Uzhachenko R.V., Maslov L.N., Bernatatskaya N.A., Markriyannis A., Mekhoulam R., et al. Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism. Bull. Exp. Biol. Med. 133 (2002) 122-124
38. Wagner J.A., Abesser M., Harvey-White J., and Ertl G. 2-arachidonylglycerol acting on CB1 receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts. J. Cardiovasc. Pharmacol. 47 (2006) 650-655
39. Kranias E.G., and Bers D.M. Calcium and cardiomyopathies. Subcell. Biochem 45 (2007) 523-537
40. 1-adrenergic receptor-induced cardiomyocyte hypertrophy. Acta Pharmacol. Sin. 27 (2006) 895-900
41. 3 type 2 deficient mice. Circ. Res. 96 (2005) 1274-1281
42. 3 signalling in cardiac myocytes. J. Physiol. 581 (2007) 883-884
43. Oakes S.A., Scorrano L., Opferman J.T., Bassik M.C., Nishino M., Pozzan T., and Korsmeyer S.J. Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 102 (2004) 105-110
44. deSouza N., Reiken S., Ondrias K., Yang Y., Matkovich S., and Marks A.R. Protein kinase A and two phosphatases are components of the inositol 1,4,5-trisphosphate receptor macromolecular signalling complex. J. Biol. Chem. 277 (2002) 39397-39400
45. 2+ flux in reconstituted lipid vesicles. J. Biol. Chem. 269 (1994) 6735-6742
46. Alexander S.P.H., and Kendall D.A. The complications of promiscuity: endocannabinoid action and metabolism. Br. J. Pharmacol. 152 (2007) 602-623